Search Results 191-200 of 22129 for ulcerative colitis

  1. Inflammatory bowel disease (IBD) - Doctors and departments - Mayo Clinic

    ... ulcerative colitis. Mayo Clinic researchers conducted the first clinical study of mesalamine and discovered that genetic differences significantly affected ...

  2. A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis - Mayo Clinic

    ... Ulcerative Colitis. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information. Overview.

  3. Inflammatory bowel disease (IBD) - Doctors and departments - Mayo Clinic

    ... ulcerative colitis. Mayo Clinic researchers conducted the first clinical study of mesalamine and discovered that genetic differences significantly affected ...

  4. A Study To Evaluate The Accuracy Of The Length-109 Probe Set Panel (A Genetic Test) In Predicting Response To Golimumab In Participants With Moderately To Severely Active Ulcerative Colitis - Mayo Clinic

    ... Ulcerative Colitis. Print details. Share; Facebook · Twitter. Overview ... ulcerative colitis (UC). Participation eligibility. Participant eligibility ...

  5. Inflammatory bowel disease (IBD) - Doctors and departments - Mayo Clinic

    ... ulcerative colitis. Mayo Clinic researchers conducted the first clinical study of mesalamine and discovered that genetic differences significantly affected ...

  6. A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis - Mayo Clinic

    ... ulcerative colitis (UC). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...

  7. Expert explains how inflammatory bowel disease, irritable bowel syndrome differ - Mayo Clinic News Network

    ... IBD, and irritable bowel syndrome, or IBS ... Inflammatory bowel disease is a group of autoimmune diseases that include ulcerative colitis and Crohn's disease.

  8. A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302) - Mayo Clinic

    ... Ulcerative Colitis (FIGARO UC 302). Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More ...

  9. Mayo Clinic: Patients with Inflammatory Bowel Disease at Higher Risk for Stroke and Heart Attack

    11–16, in San Diego. More than 1.5 million Americans have Crohn's disease or ulcerative colitis , the most common forms of inflammatory bowel disease (IBD).

  10. Inflammatory bowel disease (IBD) - Doctors and departments - Mayo Clinic

    ... colitis, Ulcerative colitis, Cro...hn's disease. Show more areas of focus for John Mark B. Gubatan, M.D.. Suryakanth Reddy R ...